LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Biologics/Horse Treatment Tried on Humans
Biologics

Horse Treatment Tried on Humans

October 22, 2014 1 min read Premium comments

Advertisement

Horse Treatment Tried on Humans
Source: Wikimedia commons and Pitke
Secondary

The treatment was first used on injured racehorses. Veterinarians had injected the animals with their own stem cells in an attempt to heal inflamed tendons.

If it works on injured racehorses, why not try it on humans? Tendons are notoriously difficult to treat as they have a poor blood supply. The horses had appeared to benefit from the injections of their own stem cells and now two studies, one in Korea and another in Great Britain, are testing the treatment on humans.

In one trial doctors at Seoul National University Hospital in South Korea are giving patients suffering from tennis elbow injections of up to ten million stem cells into the damaged tendon. Tennis elbow is triggered by overuse of the muscles and tendons of the forearm, near the elbow joint. As many as one in three people are believed to experience tennis elbow at some point, though it is more common in those over age 40.

In London, in a pilot study at the Royal National Orthopaedic Hospital involving ten patients, stem cells are being taken from each patient and then grown in a laboratory for a month before being injected into their damaged Achilles tendons. According to Roger Dobson, writing for the Daily Mail, early-stage laboratory studies, as well as reports from treating racehorses, have shown that, over several weeks, the stem cells encourage the growth of new tendon tissue and reduce scar tissue.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy